SEC Form 4

FORM 4		UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934 or Section 30(h) of the Investment Company Act of 1940	OMB APPROVAL OMB Number: 3235-0287 Estimated average burden hours per response: 0.5
	Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

1. Name and Address of Reporting Person* FANANDAKIS NICHOLAS C (Last) (First) (Middle) CHESTNUT RUN PLAZA 730 974 CENTRE ROAD (Street) WILMINGTON DE 19805 (City) (State) (Zip)	2. Issuer Name and Ticker or Trading Symbol DUPONT E I DE NEMOURS & CO [ DD ]	5. Relationship of Reporting Person(s) to Issuer (Check all applicable) Director 10% Owner X Officer (give title below) Other (specify below) Executive Vice President & CFO
	3. Date of Earliest Transaction (Month/Day/Year) 08/31/2017
	4. If Amendment, Date of Original Filed (Month/Day/Year)	6. Individual or Joint/Group Filing (Check Applicable Line) X Form filed by One Reporting Person Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	08/31/2017		D		157,590.8855(1)	D	(1)	0	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Employee Stock Options (Right to Buy)	$49.9015	08/31/2017		D			49,487(2)	(2)	02/05/2019	Common Stock	49,487	(2)	0	D
Employee Stock Options (Right to Buy)	$45.7189	08/31/2017		D			57,312(3)	(3)	02/05/2020	Common Stock	57,312	(3)	0	D
Employee Stock Options (Right to Buy)	$59.6543	08/31/2017		D			47,407(4)	(4)	02/04/2021	Common Stock	47,407	(4)	0	D
Employee Stock Options (Right to Buy)	$71.0648	08/31/2017		D			60,380(5)	(5)	02/03/2022	Common Stock	60,380	(5)	0	D
Employee Stock Options (Right to Buy)	$58.76	08/31/2017		D			84,296(6)	(6)	02/02/2026	Common Stock	84,296	(6)	0	D
Employee Stock Options (Right to Buy)	$76.17	08/31/2017		D			72,073(7)	(7)	02/01/2027	Common Stock	72,073	(7)	0	D

Explanation of Responses:

1. Disposed of pursuant to merger agreement between issuer and Dow Chemical Company in exchange for 202,028.8433 shares or stock units, as applicable, of DowDuPont common stock having a market value of $67.18 per share or stock unit, as applicable, on the effective date of the merger.

2. This option, which provided for vesting in three equal annual installments beginning February 6, 2013, was assumed by DowDuPont in the merger and exchanged for 63,422 options at a grant price of $38.93.

3. This option, which provided for vesting in three equal annual installments beginning February 6, 2014, was assumed by DowDuPont in the merger and exchanged for 73,473 options at a grant price of $35.67.

4. This option, which provided for vesting in three equal annual installments beginning February 5, 2015, was assumed by DowDuPont in the merger and exchanged for 60,775 options at a grant price of $46.54.

5. This option, which provided for vesting in three equal annual installments beginning February 4, 2016, was assumed by DowDuPont in the merger and exchanged for 77,407 options at a grant price of $55.44.

6. This option, which provided for vesting in three equal annual installments beginning February 3, 2017, was assumed by DowDuPont in the merger and exchanged for 108,875 options at a grant price of $45.84.

7. This option, which provided for vesting in three equal annual installments beginning February 2, 2018, was assumed by DowDuPont in the merger and exchanged for 92,397 options at a grant price of $59.42.

Remarks:

	Erik T. Hoover by Power of Attorney	09/05/2017
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.